Chronic myeloid leukemia: genes and variants
Explore variant evidence for Chronic myeloid leukemia across 8 analyzed proteins (ABL1, BCR, TET2, KIT, LCK and 3 more). Linked ClinVar records include 3 pathogenic or likely pathogenic variants, 5 variants of uncertain significance and 1 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Chronic myeloid leukemia
ABL1: Tyrosine-protein kinase ABL1
It coordinates cytoskeletal remodeling, adhesion, DNA-damage responses, and growth signaling through tightly regulated tyrosine phosphorylation. Fusion with BCR removes normal control and creates the constitutively active kinase that drives chronic myeloid leukemia and subsets of acute lymphoblastic leukemia.
3 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in ABL1 have source records linked to Chronic myeloid leukemia. Association strength is not clinical gene validity.
BCR: Breakpoint cluster region protein
It has serine/threonine kinase and GTPase-regulatory functions involved in cytoskeletal and signaling control. Chromosomal fusion with ABL1 creates the constitutively active BCR::ABL1 kinase that drives chronic myeloid leukemia and subsets of acute leukemia.
0 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in BCR have source records linked to Chronic myeloid leukemia. Association strength is not clinical gene validity.
TET2: Methylcytosine dioxygenase TET2
It oxidizes methylated cytosines and helps reshape DNA methylation during hematopoietic differentiation. Somatic loss-of-function variants are among the most common drivers of clonal hematopoiesis and occur frequently in myeloid malignancies.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in TET2 have source records linked to Chronic myeloid leukemia. Association strength is not clinical gene validity.
KIT: Mast/stem cell growth factor receptor Kit
Stem-cell-factor signaling through this pathway supports hematopoietic progenitors, mast cells, melanocytes, and germ cells. Activating variants drive gastrointestinal stromal tumors, systemic mastocytosis, and other malignancies, whereas loss-of-function variants can cause piebaldism.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KIT have source records linked to Chronic myeloid leukemia. Association strength is not clinical gene validity.
LCK: Tyrosine-protein kinase Lck
It phosphorylates the earliest signaling components downstream of the T-cell receptor and CD4 or CD8 coreceptors, making it essential for T-cell development and activation. Severe loss-of-function can cause combined immunodeficiency, while aberrant activity contributes to lymphoid malignancy.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in LCK have source records linked to Chronic myeloid leukemia. Association strength is not clinical gene validity.
PDGFRB: Platelet-derived growth factor receptor beta
Its signaling supports pericytes, vascular smooth-muscle cells, and other mesenchymal lineages during growth and tissue repair. Oncogenic fusions drive myeloid neoplasms, while germline activating or loss-of-function variants can cause developmental and vascular disorders.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PDGFRB have source records linked to Chronic myeloid leukemia. Association strength is not clinical gene validity.
SETBP1: SET-binding protein
It regulates transcription and protein-phosphatase signaling in development and hematopoiesis. Specific gain-of-function variants cause Schinzel-Giedion syndrome, somatic hotspot variants occur in aggressive myeloid neoplasms, and loss-of-function variants can cause a distinct speech and developmental disorder.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SETBP1 have source records linked to Chronic myeloid leukemia. Association strength is not clinical gene validity.
SRC: Proto-oncogene tyrosine-protein kinase Src
It integrates signals from growth-factor receptors, integrins, and other surface proteins to regulate proliferation, adhesion, migration, and survival. Persistent SRC-family signaling promotes invasion and therapy resistance in many cancers and remains an important therapeutic target.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SRC have source records linked to Chronic myeloid leukemia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): ASXL1 and IDH1.
ClinVar pathogenic and likely pathogenic variants linked to Chronic myeloid leukemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ABL1 T315I | 315 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| ABL1 M351T | 351 | Protein kinase | Pathogenic / likely pathogenic |
| ABL1 F311L | 311 | Protein kinase | Pathogenic / likely pathogenic |
Same protein, different disease
- Congenital heart defects and skeletal malformations syndrome also has ClinVar records linked to ABL1 variants; they fall mostly in different places as the Chronic myeloid leukemia variants (14 pathogenic / likely pathogenic).
- Leukemia, Philadelphia chromosome-positive, resistant to imatinib also has ClinVar records linked to ABL1 variants; they fall mostly in different places as the Chronic myeloid leukemia variants (5 pathogenic / likely pathogenic).
Diseases related to Chronic myeloid leukemia
- Acute lymphoid leukemia, also linked to ABL1, BCR, KIT, LCK and 2 more
- Gastrointestinal stromal tumor, also linked to ABL1, BCR, KIT and PDGFRB
- Acute myeloid leukemia, also linked to KIT, PDGFRB, SETBP1 and TET2
- Colorectal cancer, also linked to ABL1, KIT and PDGFRB
- Renal cell carcinoma, also linked to KIT, LCK and PDGFRB
- Hepatocellular carcinoma, also linked to KIT and PDGFRB
- Hypertrophic cardiomyopathy, also linked to SRC
- Noonan syndrome, also linked to SRC
- Ovarian cancer, also linked to KIT
- Severe combined immunodeficiency, also linked to LCK
- Myofibromatosis, also linked to PDGFRB
- Non-small cell lung carcinoma, also linked to PDGFRB
Frequently asked questions
Which genes have records linked to Chronic myeloid leukemia?
This view contains 8 analyzed proteins: ABL1, BCR, TET2, KIT, LCK and 3 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 3 pathogenic or likely pathogenic variants, 5 variants of uncertain significance and 1 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 17 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center